Stock listing

NASDAQ:INBX Inhibrx Inc Stock

Follow Inhibrx Inc into a list and get an email when it puts out news.

Last close · NASDAQ:INBX

$34.35 USD

Close on May 28, 2024 · No longer trades

Aug 19, 2020 to last close +66.5% · weekly closes, Aug 19, 2020 – May 28, 2024
Lowest – highest close
$8.52 – $50.00 USDSince Aug 19, 2020 · lowest Jun 14, 2022 · highest Dec 17, 2020

Delisted NASDAQ:INBX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:INBX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Inhibrx Inc on 6ix

Decks
15 decks · latest November 2023

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 13, 2026 · After close−6.8%
Quarter to Jun 30, 2026Aug 13, 2026 · After close−8.9%
Quarter to Mar 31, 2026May 14, 2026 · After close−6.5%
Quarter to Dec 31, 2025Mar 23, 2026+3.6%
Quarter to Sep 30, 2025Nov 14, 2025 · Before open+6.0%
Quarter to Jun 30, 2025Aug 13, 2025 · After close+1.6%
Quarter to Mar 31, 2025May 14, 2025 · After close+10.9%
Quarter to Dec 31, 2024Mar 17, 2025−0.7%
Quarter to Sep 30, 2024Nov 14, 2024 · After close−3.5%
Quarter to Jun 30, 2024Aug 13, 2024+0.4%
All 11 quarters
QuarterResultsShare move
Quarter to Mar 31, 2024May 29, 2024

Open Events

Decks

DeckKindSlidesDate
Inhibrx Biosciences — Investor Presentation (November 2023)Investor deck37 slidesNovember 2023
Investor Presentation (August 2023)Investor deck36 slidesAug 7, 2023
Inhibrx Biosciences — Investor Presentation (May 2023)Investor deck47 slidesMay 2023
Investor Presentation (March 2023)Investor deck47 slidesMar 6, 2023
Investor Presentation (October 2022)Investor deck49 slidesOctober 2022
Investor Presentation (May 2022)Investor deck44 slidesMay 16, 2022
Investor Presentation (April 2022)Investor deck44 slidesApr 4, 2022
Investor Presentation (January 2022)Investor deck41 slidesJan 4, 2022
Investor Presentation (October 2021)Investor deck29 slidesOctober 2021
Inhibrx Biosciences — Investor Presentation (August 2021)Investor deck29 slidesAugust 2021
All 15 decks
DeckKindSlidesDate
Investor Presentation (June 2021)Investor deck29 slidesJun 21, 2021
Inhibrx Biosciences — Investor Presentation (March 2021)Investor deck33 slidesMarch 2021
Investor Presentation (January 2021)Investor deck31 slidesJan 5, 2021
Investor Presentation (November 2020)Investor deck31 slidesNov 12, 2020
Investor Presentation (September 2020)Investor deck31 slidesSep 11, 2020

Open Decks

Cap table

Built by 6ix from Inhibrx Inc’s releases · as of Aug 7, 2026

Common shares
14,717,660
Fully diluted
14,717,660

Fully diluted

LineSharesAs of
Common shares14,717,660Aug 7, 2026

Share count over time

CountShares
Aug 7, 202614,717,660

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Kimberly Manhard
Other companies: Connect Biopharma Holdings Limited (CHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026); Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024); Heron Therapeutics, Inc. (EVP, Drug Development · Jan 10, 2014 – Apr 13, 2023 · Past); Ardea Biosciences Inc (SVP, Regulatory & Dev Ops · Oct 28, 2011 – Jun 19, 2012 · Past)
Director · Aug 18, 2020 – May 30, 2024 · Past
Jon Faiz Kayyem
Other companies: Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024); Biodesix, Inc. (Director · Since at least Jan 1, 2024)
Director · May 30, 2024 – May 30, 2024 · Past
Brendan P Eckelman
Other companies: Inhibrx Biosciences, Inc. (Chief Scientific Officer · May 24, 2024 – May 29, 2024 · Past)
Chief Scientific Officer · Aug 18, 2020 – May 28, 2024 · Past
Douglas G. Forsyth
Other companies: Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024)
Director · Aug 18, 2020 – May 30, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Inhibrx Inc.